Skip to main content
. 2016 Sep 19;7(42):68933–68942. doi: 10.18632/oncotarget.12112

Table 3. Response rate in EGFR+ according to BIM-del status.

Response rate BIM-del+ N=14 (%) BIM del- N=75 (%) P
Response to TKIs
 Yes 5 (35.7) 55 (73.3) 0.002
 No 9 (64.3) 20 (26.7)
Response to chemotherapy
 Yes 4 (28.6) 24 (32.0) 0.67
 No 5 (35.7) 23 (30.7)
 ND 5 (35.7) 28 (37.3)